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No study to date has comparedmultilocus variable-number tandem-repeat analysis (MLVA) and whole-genome sequencing
(WGS) in an investigation of the transmission of Clostridium difficile infection. Isolates from 61 adults with ongoing and/or re-
current C. difficile infections and 17 asymptomatic carriage episodes in children (201 samples), as well as from 61 suspected out-
breaks affecting 2 to 41 patients in 31 hospitals in the United Kingdom (300 samples), underwent 7-locus MLVA andWGS in
parallel. When the first and last samples from the same individual taken for a median (interquartile range [IQR]) of 63 days (43
to 105 days) apart were compared, the estimated rates of the evolution of single nucleotide variants (SNVs), summed tandem-
repeat differences (STRDs), and locus variants (LVs) were 0.79 (95% confidence interval [CI], 0.00 to 1.75), 1.63 (95% CI, 0.00 to
3.59), and 1.21 (95% CI, 0.00 to 2.67)/called genome/year, respectively. Differences of>2 SNVs and>10 STRDs have been used
to exclude direct case-to-case transmission.With the first serial sample per individual being used to assess discriminatory power,
across all pairs of samples sharing a PCR ribotype, 192/283 (68%) differed by>10 STRDs and 217/283 (77%) by>2 SNVs.
Among all pairs of cases from the same suspected outbreak, 1,190/1,488 (80%) pairs had concordant results using>2 SNVs and
>10 STRDs to exclude transmission. For the discordant pairs, 229 (15%) had>2 SNVs but<10 STRDs, and 69 (5%) had<2
SNVs but>10 STRDs. Discordant pairs had higher numbers of LVs than concordant pairs, supporting the more diverse measure
in each type of discordant pair. Conclusions on whether the potential outbreaks were confirmed were concordant in 58/61 (95%)
investigations. Overall findings usingMLVA andWGS were very similar despite the fact that they analyzed different parts of the
bacterial genome.With improvements inWGS technology, it is likely that MLVA locus data will be available fromWGS in the
near future.
Molecular typing significantly enhances Clostridium difficileoutbreak investigation and transmission studies, as well as
informing surveillance efforts (1, 2). PCR ribotyping and pulsed-
field gel electrophoresis (PFGE) are currently the most frequently
used typing techniques in Europe and North America, respectively
(1). However, multilocus variable-number tandem-repeat analysis
(MLVA) (3–5) and whole-genome sequencing (WGS) of C. difficile
(6, 7) both offer increased discrimination over other typing schemes.
MLVA exploits variations in the copy number at7 tandem-
repeat loci to distinguish isolates. Differences between the isolates
are reported in terms of the number of loci at which they differ
(locus variants [LVs]) and the sum of the absolute differences in
copy number at each locus (summed tandem-repeat difference
[STRD]). WGS can be used to compare single nucleotide variants
(SNVs) between isolates across the nonrepetitive core genome,
which accounts for 80% of the 4.3 million-base pair C. difficile
strain 630 reference genome (6–8).MLVA andWGS analyze com-
pletely different parts of the C. difficile genome and reflect differ-
ent evolutionary processes; they may therefore have differing per-
formances as tools for C. difficile surveillance and epidemiology.
An ideal typing scheme is reproducible and able to discrimi-
nate efficiently between isolates from a given population of inter-
est. In contrast to categorical typing schemes, like ribotyping and
PFGE, WGS and MLVA continuously grade the relatedness of
isolates. This has the potential to allow for the reconstruction of
transmission chains by tracking the accumulation of changes over
time and in different hosts. An ideal metric changes monotoni-
cally with time, without significant back mutation. To follow in-
fections between successive hosts, the rate of change should be low
enough that transmitted isolates are clearly related but sufficiently
high relative to the rate of transmission and within-host diversity
for changes to accumulate in successive hosts that allow for the
transmission chains to be ordered. The extent of within-host vari-
ation during a single infection should also be low compared with
the population diversity.
With MLVA, reproducibility has been assessed by repeated
culture of the same strain and serial subculture, and1 STRDwas
observed (1 strain was cultured 5 times, and 5 strains were serially
subcultured 10, 11, 11, 11, and 30 times) across 2 studies (9, 10).
One strain had evidence of expansion and reversion of a single
locus by 1 repeat during subculture (9). Differences of up to 1
repeat unit per locuswere seen in a comparison of agarose gels and
capillary sequencing, highlighting the contribution of the assay
method to the detection of variations (11). Within-host diversity
was assessed by typing five colonies from the same specimen, and
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34/39 (87%) colonies had 2 STRDs. The extent to which the
diversity observed in the remaining five cases (5 to 24 STRDs)
represents a mixed infection with another strain is unclear, as all
isolates were from the highly prevalent epidemic C. difficile
ribotype 027 (11). Across two studies, in 13 serially sampled pa-
tients with samples 2 days to 8 months apart, up to 3 STRDs were
observed, with 2 STRDs after 2 days in 1 patient and 3 STRDs after
20 days in another (3, 10). These data have led to the consensus
that isolates2 STRDs apart should be regarded as indistinguish-
able. The clustering of cases 3 to 10 STRDs apart within diverse
strain collections (3, 12) has led to such cases being regarded as
closely related, consistent with local outbreaks (5, 13, 14). How-
ever, a recent analysis of 117 recurrent episodes usingMLVAhigh-
lights the uncertainty surrounding howmany STRDs are compat-
ible in the same infection over time, with 16 recurrent episodes
having between 3 and 9 STRDs (15). Extensions to the original
MLVA scheme using 14 or 15 loci have been proposed as alterna-
tives to the combination that is typically used of PCR ribotyping
followed by 7-locus MLVA (16, 17).
With WGS, the appropriate data processing pipelines result in
1 false SNV identified per 100 genomes sequenced (based on 66
genomes that were sequenced between 2 and 8 times) (7). The
rates of C. difficile evolution estimated from 91 serially sampled
patients and a global collection of ribotype 027 strains are similar,
at1 to 2 SNVs per genome per year (7, 18). From serially sam-
pled patients and five samples with 12 colonies sequenced from
each patient, the extent of within-host diversity is typically 1
SNV (7, 19).
To compare the utility of MLVA versus WGS in outbreak in-
vestigations, we first investigated a comprehensive set of serially
sampled adults with ongoing or recurrent C. difficile infections
(CDI) and asymptomatic children (aged2 years) using the two
methods. The performance ofMLVAversus that ofWGSwas then
compared across 61 potential CDI outbreaks (5).
MATERIALS AND METHODS
Patients/participants and samples. Serially sampled adults with ongoing
or recurrent CDIs were identified from a collection of all hospital and
community samples from the county of Oxfordshire, United Kingdom,
between September 2006 and July 2010,whichwas previously described in
detail (2, 20). Toxin enzyme immunoassay (EIA)-positive samples under-
went culture and multilocus sequence typing (MLST) (21). Three hun-
dred twenty-five patients were identified with the same sequence type on
multiple samples. Sixty-one of these patients were selected at random for
further study using MLVA and WGS (148 samples; 40 patients had 2
samples, 16 had 3 samples, and 5 had 4 samples).
Samples were also obtained from an ongoing study of C. difficile car-
riage in asymptomatic children aged2 years (22) to assess if this group,
who were without symptoms and not subject to antibiotic treatment, had
different rates ofC. difficile evolution andwithin-host diversity. Following
parental consent, longitudinal samples were obtained at approximately
monthly intervals for up to 9 months. Sixteen children carrying the same
C. difficile ribotype for1 month were included; one child had two epi-
sodes of carriage with two different ribotypes, providing a total of 17
participant-ribotype carriage episodes for study using MLVA and WGS
(eight lasting 2months, three lasting 3months, one lasting 4months, four
lasting 5 months, and one lasting 6 months).
Sixty-one potential CDI outbreaks involving 300 patients from 31
hospitals in the United Kingdom were investigated using MLVA and
WGS. These samples were submitted to the C. difficile Ribotyping Net-
work for England and Northern Ireland (CDRN) between June 2007 and
July 2011 by hospitals in which there was clinical suspicion of an outbreak
based on a clustering of cases in a particular time and space. Isolates from
these clusters of cases found to share a ribotype underwent analysis with
MLVA, as presented previously (5), and underwent whole-genome se-
quencing in this study.
MLVA. MLVA was performed as described previously (5). Briefly,
seven regions within the C. difficile genome known to contain short tan-
dem repeats, designated A6, B7, C6, E7, F3, G8, and H9, were targeted.
Three separate PCR duplexes (A6-G8, B7-F3, and C6-E7) and one single
PCR (H9) were used. The forward PCR primers for all loci were labeled
with either 6-carboxyfluorescein (FAM), PET, 2=-chloro-5=-flouro-7=,8=-
fused phenyl-1,4-dichloro-6-carboxyfluorescein (NED), or 2=-chloro-7=-
phenyl-1,4-dichloro-6-carboxyfluorescein (VIC). Repeats were amplified
using a single protocol (9). PCR fragments were analyzed using multicol-
ored capillary electrophoresis on an ABI3130xl genetic analyzer, with
GeneScan 600 LIZ as an internal marker. Fragment sizes were determined
with the GeneMapper software (Applied Biosystems, Life Technologies,
Grand Island,NY). TheMLVAamplification conditionswere adjusted for
PCR ribotypes 078 and 017 due to potential sequence mismatches in the
primer annealing sites for the loci A6, B7, C6, and G8 (A6 is absent in
ribotype 078) (23). For ribotypes with potential mismatches in the primer
annealing sites, and for those not previously evaluated using MLVA, se-
lected isolates were sequenced to verify the accuracy of assignments of
repeat numbers (data not shown).
Whole-genome sequencing.DNA for sequencingwas extracted using
a commercial kit (QIAamp [Qiagen, Hilden, Germany] or QuickGene
[Fujifilm, Tokyo, Japan]). Samples were prepared for sequencing using
standard Illumina (San Diego, CA) and adapted protocols. Pools of 96
samples were sequenced at theWellcome Trust Centre forHumanGenet-
ics, Oxford, United Kingdom, on the Illumina HiSeq 2000 platform, gen-
erating 100-bp reads. Properly paired sequence reads were mapped using
Stampy version 1.0.17 (without Burrows-Wheeler Aligner premapping,
using an expected substitution rate of 0.01) (24) to the C. difficile 630
reference genome (GenBank accession no. AM180355.1) (8).
Single nucleotide variants (SNVs) were identified across all mapped
nonrepetitive sites using SAMtools (version 0.1.18) (25)mpileupwith the
extended base-alignment quality flag, after parameter tuning was per-
formed based on bacterial sequences (options -E -M0 –Q25 -q30 -m2 -D
-S; other values were defaults). Repetitive regions were identified using
BLAST (26) searches of the reference genome using fragments of the same
genome. GATK version 1.4.21 (27) was used to create variant call format
(VCF) files of the annotated variant sites. We used only SNVs that were
supported by 5 reads, including one in each direction. A consensus of
90%of high-quality bases (Phred scaled quality,25) was also required
to support an SNV, and calls had to be homozygous under a diploid
model. The calls required the proportion of bases of quality of 25 in
reads spanning the site of interest to be 0.35. A median (interquartile
range [IQR]) of 84.0% (83.8% to 84.8%) of the C. difficile 630 reference
genome was called across all sequenced isolates.
Adjustment for any clustering of SNVs that was suggestive of recom-
bination was undertaken using the method described in Golubchik et al.
(28). The parameter values for the recombination adjustment were ob-
tained from Didelot et al. (7). In cases in which the parameters were not
available for a specific lineage, they were obtained from the genetically
closest lineage.
Analysis. Models were fitted to data from the first and last samples
from serially sampled adults and children to evaluate the relationship
between variations in SNVs, STRDs, LVs (s), and time (t). SNVs, STRDs,
and LVs were assumed to arise as the combination of a time-dependent
Poisson process, representing evolution (at a rate of  events per unit of
time), and a time-independent Poisson process () representing within-
host diversity and assay variation (29): s Pois(t ).
To confirm evidence for detectable evolution, a separate model was
fitted without the time-dependent term (t) and compared. We also in-
vestigated evidence for an excess of samples with zero variants, consistent
with a subset of recurrences arising from spores with arrested evolution.
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In this zero-inflated Poisson model, samples had a time-independent
probability of having zero variants, and otherwise, variants were assumed
to arise as in the main model.
Models were fitted by themaximum-likelihoodmethod using numer-
ical optimization in R version 2.15.3 (see http://www.r-project.org), with
the rates of evolution and within-host diversity and assay variation con-
strained to be positive. Model comparisons were undertaken using the
Akaike information criterion (AIC). Confidence intervals were generated
by parametric bootstrap analysis using 1,000 iterations. In a sensitivity
analysis, estimates were recalculated after excluding a single outlying pair
of samples separated by 561 days.
Nucleotide sequence accession number. The sequences reported in
this paper have been deposited in the European Nucleotide Archive Se-
quence Read Archive under study accession no. PRJEB4640 and are avail-
able at http://www.ebi.ac.uk/ena/data/view/PRJEB4640.
RESULTS
MLVA andWGS within a host over time. The first and last sam-
ples obtained from 61 adult CDI cases with ongoing or recurrent
infection and 17 pediatric C. difficile carriage episodes were com-
pared using MLVA and WGS. One CDI case with a probable ri-
botype 027 reinfectionwas excluded (the last sample had 16 SNVs,
6 LVs, and 31 STRDs different from the first). The remaining 77
sample pairs were obtained a median (IQR) (range) of 63 (43 to
105 days) (2 to 561 days) days apart.
There was evidence of evolution in the numbers of SNVs,
STRDs, and LVs over time; models that included an evolution
term showed a better fit to the data than those without (Table 1).
The difference in model fit with and without evolution was most
marked for SNVs. The estimated rates of evolution in the numbers
of SNVs, STRDs and LVs over time were 0.79 (95% CI, 0.00 to
1.75), 1.63 (95% CI, 0.00 to 3.59), and 1.21 (95% CI, 0.00 to
2.67)/called genome/year, respectively (Fig. 1). By all three mea-
sures, there was evidence of within-host diversity or intrinsic assay
variation, as demonstrated by a significant number of differences
estimated at a t value of 0 (intercept), namely, 0.29 SNVs (95%CI,
0.05 to 0.53), 1.91 STRDs (95% CI, 1.37 to 2.40), and 0.92 LVs
(95%CI, 0.54 to 1.28). Relative to the rates of evolution, there was
the least amount of within-host diversity using SNVs, with which
it took 0.37 years to generate the same amount of diversity by
evolution as observed at baseline, compared to 1.17 years with
STRDs and 0.76 years with LVs (Table 1).
The broad confidence intervals, including zero for evolution-
ary rates in all threemeasures, likely reflect the limited sample size
that underwent both MLVA and WGS. For example, fitting the
same model to a previously reported set of WGS data from 145
serially sampled cases (which includes the current adult cases)
(19) estimates a rate of evolution of 0.86 (95% CI, 0.23 to 1.50)
SNVs/called genome/year (Fig. 1A, dotted line). In a sensitivity
analysis, when the models were fitted without an outlying pair of
samples separated by 561 days and 0 SNVs, 4 STRDs, and 3 LVs,
only the estimated rate of evolution for SNVs changed apprecia-
bly, to 1.30 (95% CI, 0.10 to 2.48) SNVs/called genome/year. For
SNVs and LVs, there was no evidence to support different rates of
evolution and within-host diversity for symptomatic adults and
asymptomatic children (AIC for the combined SNVmodel, 149.7,
versus separate adults and children model, 152.9, and for the LV
models, 209.9 versus 214.4 [with lower values indicating a better
model fit], respectively). For STRDs, including separate rates for
adults and children improved the model fit (AIC, 383.7 for the
combined model versus 373.5 for the separate model), with higher
estimated rates of evolution in children (adults, 1.24 [95%CI, 0.00 to
3.67] versus children, 3.09 [95% CI, 0.00 to 6.29] STRDs/called ge-
nome/year), but lower rates of within-host diversity (2.31 [95% CI,
1.70 to 2.87] versus 0.47 [95% CI, 0.00 to 1.24] STRDs/called ge-
nome).
TABLE 1 Rates of evolution and baseline diversitya
Variant types Model description
Evolution per yr
(no. [95% CI])
Within-host diversity
(no. [95% CI])
Estimated proportion
with fixed zero
diversity
(no. [95% CI])
Model
AICb
Time to evolution
equaling within-
host diversity (yr)
Single nucleotide
variants
Within-host diversity only 1.00 (1.00–1.22) 175.6
Evolution and within-host diversity 0.79 (0.00–1.75) 0.29 (0.05–0.53) 149.7 0.37
Evolution, within-host diversity,
and proportion with zero
diversity
2.02 (0.00–4.15) 0.36 (0.00–0.88) 0.41 (0.00–0.62) 146.6 0.18
Summed
tandem-repeat
differences
Within-host diversity only 2.30 (1.97–2.64) 383.5
Evolution and within-host diversity 1.63 (0.00–3.59) 1.91 (1.37–2.40) 382.7 1.17
Evolution, within-host diversity,
and proportion with zero
diversity
0.66 (0.00–3.28) 2.76 (2.03–3.33) 0.22 (0.11–0.32) 363.2 4.21
Locus variants Within-host diversity only 1.21 (1.00–1.47) 211.5
Evolution and within-host diversity 1.21 (0.00–2.67) 0.92 (0.54–1.28) 209.9 0.76
Evolution, within-host diversity,
and proportion with zero
diversity
1.21 (0.00–2.77) 0.92 (0.54–1.34) 0.00 (0.00–0.18) 211.9 0.76
a Three models were fitted for each of the following: single nucleotide variants, summed tandem-repeat differences, and locus variants. The within-host-diversity-only model allows
for variants to arise as a time-independent Poisson process. The evolution and within-host-diversity model allows for variants to arise and a combination of a time-dependent
Poisson process to represent evolution and a time-independent Poisson process to represent within-host diversity or assay variation. The final model, evolution, within-host
diversity, and proportion with zero diversity, allows for a proportion of pairs to have arrested evolution such that the proportion of pairs with zero variants is inflated; otherwise,
variants arise as in the evolution and within-host-diversity model.
b AIC, Akaike information criterion. Lower values indicate a better model fit. Values can be compared within the SNV, STRD, and LV sections but not across sections.
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Across all threemeasures, SNVs, STRDs, and LVs, there was no
consistent evidence that models allowing for arrested evolution,
e.g., in a spore state, in a proportion of cases were a better fit to the
data. For SNVs, there was marginal evidence for a better model fit
allowing for arrested evolution, and there was stronger support
for this model with STRDs; however, for LVs, the model without
any arrested evolution was the best fit (Table 1).
The A6, B7, and C6MLVA loci varied themost over time, with
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FIG 1 Numbers of single nucleotide variants, summed tandem-repeat differences, and locus variants arising over time. Shown are samples from 60 patients with
CDI (gray diamonds) and 17 infant asymptomatic carriage episodes (black circles). The dashed line shows the fitted rate of evolution, and the shaded area
represents the 95% confidence interval for the fitted line. A single pair of samples separated by 561 days with 0 SNVs, 4 STRDs, and 3 LVs was not plotted for ease
of visualization. In the top panel, the fitted rate of evolution using the same model and data from a previously published collection (19) of 145 serially sampled
patients is shown with a dotted lined for comparison.
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no changes seen in E7 orH9 repeat numbers between first and last
samples from each host (Fig. 2). At locus C6, there appeared to a
slight asymmetry in the changes in tandem-repeat numbers, with
large decreases being more common than large increases. In 29
adults and children sampled more than twice (excluding the
ribotype 027 reinfection described above), there were multiple
instances of change followed by reversion in SNVs and in the
A6, B7, and C6 loci (Fig. 3), which is consistent with within-
host variation, assay variation, or back mutation. Most changes
were 1 repeat or SNV, although several larger changes in
MLVA loci were seen.
Within the serial samples, there was minimal correlation be-
tween SNVs and STRDs, (Spearman’s rho	 0.10, P	 0.40) and
between SNVs and LVs (rho	 0.10, P	 0.38); however, many of
the serial sample pairs had zero SNVs between them (Fig. 4).
When the first samples from each host across different hosts shar-
ing the same ribotype were compared, such that the numbers of
SNVs, STRDs, and LVs observed were greater than those within
the same host, there was still a limited correlation between SNVs
and STRDs (rho 	 0.22, P 	 0.005) but a moderate correlation
between SNVs and LVs (rho	 0.53, P 0.001).
Relative discriminatory powers across serial samples. The
first sample from each CDI case and the first sample from each C.
difficile carrier were considered in the pairwise comparisons in
order to assess the relative discriminatory powers of MLVA and
WGS across the Oxfordshire carriage and disease isolates. Isolates
with2 SNVs (19) and10 STRDs (5, 13, 14) have been used to
exclude direct transmission. Across pairs of samples sharing the
same ribotype, 192/283 (68%) were10 STRDs apart compared
with 217/283 (77%) that were different by 2 SNVs. Without
prior conditioning on ribotype, 2,898/3,003 (97%) pairs were dis-
tinct on MLVA compared with 2,936/3,003 (98%) using WGS.
Performance for investigating outbreaks. Sixty-one same-
ribotype potential outbreaks involving 300 patients from 31 dif-
ferent hospitals in the United Kingdom were investigated using
MLVA and WGS in parallel. Initially, all pairs of patients within
each outbreak were compared. As above, transmission between
pairs of cases was excluded by WGS and MLVA where pairs of
cases were separated by 2 SNVs or 10 STRDs, respectively.
Overall, 1,190/1,488 (80%) pairs of patients had concordant re-
sults onMLVA andWGS, with transmission possible between 945
(64%) pairs and excluded between 245 (16%) pairs (Table 2).
Among the pairs of cases found to be consistent with transmission
according to the two measures, there were pairs that were indis-
tinguishable by WGS while showing differences by MLVA, and
vice versa (Table 3).
However, 229 (15%) pairs had 2 SNVs between them but
10 STRDs, therefore excluding transmission on the basis of
WGS cutoffs, where transmission was considered plausible with
the use of MLVA thresholds. Similarly, 69 (5%) pairs were found
to be related byWGS but were distinct byMLVA.Within the pairs
with discordant transmission classifications, there were multiple
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FIG 2 Tandem-repeat differences over time by MLVA locus. Shown are samples from 60 patients with CDI (gray diamonds) and 17 infant asymptomatic
carriage episodes (black circles). A single pair of samples separated by 561 days with1 A6,1 B7, and2 C6 repeats was not plotted for ease of visualization.
No repeat changes were observed in locus E7 or H9.
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instances of pairs of cases 2 SNVs apart but that had relatively
few STRDs between them, including as few as 2 or 3 STRDs, i.e.,
that were within the STRD diversity expected from repeated test-
ing of the same host at a given point in time from themodels fitted
above. Similarly, there were instances of 2 SNVs when 20
STRDs were present (Fig. 5).
In pairs that were 10 STRDs apart, the median numbers of
(IQR) LVs between pairs2 versus2 SNVs apart were 1 (0 to 2)
and 3 (3 to 4), respectively (rank sum P	 0.001) (Table 2). This
suggests that the extra discrimination from higher numbers of
SNVs with few STRDs might be genuine, since the multiple LVs
are consistent with the evolution seen in SNVs, despite the
changes in repeat number at each locus that did not summate
sufficiently to reach the STRD threshold. Similarly, pairs2 SNVs
apart with 10 STRDs also had higher numbers of LVs, with a
median (IQR) 3 (2 to 4), versus pairs with 10 STRDs (P 	
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0.001), suggesting that these are not just large changes in repeat
numbers at a single locus butmay also reflect genuine discrimina-
tion from higher numbers of STRDs with low numbers of SNVs.
Outbreak classification based on WGS and MLVA. We also
investigated whether the conclusion reached in each potential
outbreak investigation based on MLVA would be changed using
WGS. Each of the 61 potential outbreaks was classified as (i) all
cases belonging to a single outbreak, (ii) all cases being unrelated,
or (iii) a mix of related and unrelated cases (5). The classifications
were concordant in 58/61 (95%) outbreaks (Table 4). Each of the
3 discordant classifications was explained by a discordant finding
in only one case in the investigation. In two cases, WGS appeared
to provide the more plausible classification, while in the third, the
MLVA result appeared to be more plausible.
DISCUSSION
In this study, we have shown that despite the fact that completely
separate regions of the bacterial genome were targeted, the con-
clusions reached in outbreak investigations using MLVA and
WGSwere largely concordant. AlthoughWGSoffers slightlymore
discrimination overall, therewere also instances whereMLVAdif-
ferentiated between cases that were shown to be highly related
using WGS.
Both STRDs or LVs and SNVs evolve relatively slowly, such
that most of the variation observed over short time periods is
dominated by pre-existing within-host diversity and assay varia-
tion; i.e., the numbers of evolutionary events are low. Over short
time periods, the stochastic nature of the changes seen in SNVs
and STRDs or LVs is reflected in the relatively low correlation seen
between these measures in serially sampled individuals. The
thresholds for excluding transmission need to account for sto-
chastic evolutionary events; for example, based on a 95% predic-
tion interval, up to 2 SNVs may be consistent with transmission
with a zero time difference, despite the expected number of SNVs
being as low as 0.29. Given the relatively low rates of evolution
comparedwith onward transmission times, genetic datamay need
to be combined with epidemiological data and/or probabilistic
models in order to accurately reconstruct individual transmission
chains. Over longer periods of evolution, such as in comparisons
of samples from hosts that are not related by direct transmission
(Fig. 4C and D), more evolutionary events occur, lessening the
impact of individual stochastic events, and this is reflected in the
moderate correlation observed between SNVs and LVs over lon-
ger time periods.
Interestingly, although relatively few serial samples from
asymptomatically colonized children were included and therefore
the power to detect those differences with samples from adults is
limited, changes in SNVs and LVs were similar to those from
adults with ongoing or recurrent CDI. This suggests that the esti-
mates of within-host diversity and evolution from this study are
likely to be generalizable. Although the best-fitting models sug-
gested there might be less STRD within-host diversity in asymp-
tomatic children, they estimated the rate of STRD evolution to be
higher than that in adults. Given the relatively small sample size,
small improvements in model fit, and the fact that this was not
seen for SNVs and LVs, the importance of this finding is unclear.
If WGS is used to exclude transmission, it is important to con-
TABLE 3 Classification of 945 pairs of same-ribotype cases within 2
SNVs and 10 STRDs across 61 potential CDI outbreaks in the United
Kingdoma
No. of SNVs
(WGS result)
No. of STRDs (MLVA result)
2 (indistinguishable) 3–10 (highly related)
0 (indistinguishable) 395 (27), 1 (0–1) 108 (7), 3 (2–3)
1–2 (highly related) 212 (14), 1 (0–2) 230 (15), 3 (2–3)
a Pairs considered to be consistent with transmission (2 SNVs,10 STRDs) were
subdivided by whether or not the pairs were considered indistinguishable (0 SNVs, 0 to
2 STRDs) (% of all isolates). Each cell contains the number of pairs and the percentage
of the total number of pairs, followed by the median number (IQR) of LVs in each cell.
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FIG 5 Relationship between STRD andWGS transmission classification. Iso-
lates with2 STRDs are regarded as indistinguishable, and isolates with10
STRDs and2 SNVs have been described as consistent with transmission.
TABLE 4 Comparison of outbreak classification using WGS and MLVA
WGS classification
MLVA classification
Single outbreak No transmission Mix
Single outbreak 33a 0 1b
No transmission 0 10a 1c
Mix 1d 0 15a
a Concordant findings. Each of the 3 discordant classifications was explained by a
discordant finding in only one case in the investigation. See footnotes b to d for
explanations.
b Ribotype 106 (12 cases), single case of10 STRDs apart from closest case, with 13
STRDs, 3 LVs, and 2 SNVs, with all other cases within 7 STRDs and 2 SNVs.
c Ribotype 015 (7 cases), single pair of cases with10 STRDs, 4 STRDs, 3 LVs, and 12
SNVs, with all other cases10 STRDs from all others, all cases4 SNVs apart.
d Ribotype 027 (3 cases), one case 16 SNVs distinct to next closest case, but 10 STRDs
(and 4 LVs) different, all other pairs of cases within 0 SNVs and 4 STRDs.
TABLE 2 Classification of 1,488 pairs of same-ribotype cases across 61
potential CDI outbreaks in the United Kingdoma
No. of SNVs (WGS
transmission result)
No. of STRDs (MLVA transmission result)
10 (transmission
possible)
10 (transmission
excluded)
2 (transmission
possible)
945 (64), 1 (0–2) 69 (5), 3 (2–4)
2 (transmission
excluded)
229 (15), 3 (3–4) 245 (16), 4 (4–5)
a Each cell contains the number of pairs and the percentage of the total number of
pairs, followed by the median number (IQR) of LVs in each cell.
MLVA versus WGS for C. difﬁcile Transmission Studies
December 2013 Volume 51 Number 12 jcm.asm.org 4147
sider recombination. In our data set, it was uncommon for pairs of
samples 2 SNVs apart, including all identified variants, to be2
SNVs apart after adjustment for recombination; this occurred
once in a serial sample pair and once in a transmission cluster.
However, if this is not accounted for, transmission may be falsely
excluded. As MLVA loci occur at sites that are widely distributed
throughout the genome (9), changes at multiple loci are highly
unlikely to be introduced by a single recombination event.
BothMLVA andWGSmethods require specific expertise. Lab-
oratory experience is required to generate reproducible MLVA
results, which may require specific conditions for some PCR
ribotypes, and also to generate consistentWGS output. Both tech-
niques also require specific software for analysis; at present, end-
to-end commercial solutions for MLVA data are available,
whereas sequence data are processed on research pipelines. How-
ever, the analysis of data from WGS is likely to become increas-
ingly automated (30).WGS also offers additional benefits, includ-
ing the reconstruction of long-term evolutionary histories and in
silico determination of virulence factors and antimicrobial resis-
tance (30). The reagent cost for MLVA in this study was $42 com-
pared to $65 forWGS.MLVA andWGS required similar amounts
of hands-on time, with 16 h of hands-on time to process 96
samples, which equates to10 min per sample.
The main limitation of this work and similar studies (15) is in
the efforts to establish which serially sampled individuals are con-
sistently infected with the same single strain as opposed to being
reinfected with a distinct strain. By prior conditioning on ribotyp-
ing in this study, clear reinfections were removed. However, rein-
fections with the same ribotype are still possible but likely consti-
tute only a minority of our cohort. Similarly, although the
potential outbreak cases were closely related in time and space, the
exact chain of transmission is unknown.
In summary, the MLVA andWGSmethods offer broadly sim-
ilar enhanced discrimination over other genotyping methods in
outbreak investigations, and they offer similar per sample costs
and laboratory time requirements (according to current prices
and technology). Of note, we were unable to predict the MLVA
loci from the WGS included here, a consequence of the length of
the repetitive regions (up to 306 bp) compared with reads of 100
bp. As WGS read lengths continue to increase, it will become
possible to perform in silicoMLVA on the currentMLVA loci and
across other repetitive regions. It is therefore likely that WGS will
soon be able to exploit both variations in repeat numbers and
single nucleotide variants, allowing for the benefits of MLVA and
current WGS methods to be delivered by a single platform.
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